C. Trautwein

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

Hiroaki Tanaka, Hans-Georg Rammensee, Steffen Walter, 2012, Nature Medicine.

Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy.

Hans-Georg Rammensee, Steffen Walter, Christel Herold-Mende, 2012, Brain : a journal of neurology.

Splenectomy of rats selectively reduces lymphocyte function-associated antigen 1 and intercellular adhesion molecule 1 expression on B-cell subsets in blood and lymph nodes.

P. Jecker, N. Milićević, J. Westermann, 2001, Blood.

Clinical characteristics and outcome of patients with enterococcal liver abscess

R. Schmid, A. Stallmach, C. Trautwein, 2021, Scientific Reports.

Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application

T. Brinker, H. Grabsch, J. Chang-Claude, 2022, ESMO open.

Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy

H. Rammensee, S. Stevanović, O. Schoor, 2013, Journal of Neuro-Oncology.

Identification of Naturally Processed Hepatitis C Virus-Derived Major Histocompatibility Complex Class I Ligands

Volker Brass, Hans-Georg Rammensee, Darius Moradpour, 2012, PloS one.

Abstract 2396: IMA950: A novel multi-peptide cancer vaccine for treatment of glioblastoma

H. Rammensee, S. Stevanović, O. Schoor, 2010 .